Nanotecnoloxías aplicadas ao deseño de sistemas de liberación de fármacos
NANOBIOFAR
Universitat de Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Universitat de Barcelona (6)
2024
-
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
Vaccines, Vol. 12, Núm. 1
-
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)
npj Vaccines
-
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium
Emerging Microbes and Infections, Vol. 13, Núm. 1
-
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
npj Vaccines, Vol. 9, Núm. 1
2000
-
Aceclofenac-loaded poly-ε-caprolactone nanocapsules. Effect of coadjuvants on morphometrical properties and drug entrapment
Bollettino Chimico Farmaceutico, Vol. 139, Núm. 3, pp. 114-119
1991
-
Interaction of amikacin loaded nanoparticles with phosphatidylcholine monolayers as membrane models
International Journal of Pharmaceutics, Vol. 67, Núm. 2, pp. 103-112